Movano Inc., doing business as Movano Health, is engaged in developing a suite of healthcare solutions to bring medical-grade data to the forefront of wearables. Its devices deliver data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and translating it into personalized and intelligent insights. Its product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.
Ticker SymbolMOVE
Company nameMovano Inc
IPO dateMar 23, 2021
CEODr. John Mastrototaro, Ph.D.
Number of employees32
Security typeOrdinary Share
Fiscal year-endMar 23
Address6800 Koll Center Parkway
CityPLEASANTON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code94566
Phone14083931209
Websitehttps://movanohealth.com/
Ticker SymbolMOVE
IPO dateMar 23, 2021
CEODr. John Mastrototaro, Ph.D.
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data